The United States Embolization Devices Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Embolization Devices Market By Application
- Oncology
- Peripheral Vascular Disease
- Neurology
- Urology
- Cardiology
Embolization devices are crucial in various medical applications within the United States healthcare sector. In oncology, these devices are employed for treating tumors by obstructing the blood supply to cancerous growths, thereby reducing their size or eliminating them. The growing incidence of cancer and advancements in embolization techniques contribute significantly to the market’s growth in this segment.
Peripheral vascular disease represents another key application area, where embolization devices help manage conditions like aneurysms and control bleeding. In neurology, these devices are used for treating cerebral aneurysms and arteriovenous malformations, offering minimally invasive alternatives to traditional surgery. Furthermore, embolization devices play a crucial role in urology for conditions such as benign prostatic hyperplasia (BPH), offering patients non-surgical treatment options.